{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:37:10Z","timestamp":1789141030583,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Khan Family Fund"},{"name":"Arena of Care Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Biases in healthcare pose challenges for inflammatory bowel disease (IBD) patients from underrepresented races and ethnicities. Our study aimed to assess the quality of and access to care among underrepresented racial and ethnic populations using a diverse database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the OneFlorida Data Trust, representing over half of Florida\u2019s population. We performed a retrospective study from 2012 to 2020. Advanced IBD therapies included a prescription of at least 1 biologic agent or tofacitinib. Disease activity markers included C-reactive protein (CRP), hemoglobin (Hgb), albumin, and white blood cell (WBC). Regression analyses compared the rates of medication use, healthcare utilization, and disease severity by race and ethnicity. Geographic distribution of advanced IBD therapy was analyzed at the county level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study included 10\u2005578 patients. Hispanic patients utilized more biologics than non-Hispanic White (NHW) patients (odds ratio [OR]: 1.3, P\u202f&amp;lt;\u202f.0001). Non-Hispanic Black patients utilized more steroids than NHW (OR: 1.2, P\u202f=\u202f.0004). Hispanics had fewer visits to emergency departments (EDs) and fewer admissions compared with NHW (OR: 0.7 and 0.6, respectively; P\u202f&amp;lt;\u202f.0001). Non-Hispanic Black patients visited ED more frequently than NHW patients (OR: 1.3, P\u202f&amp;lt;\u202f.0001). Hispanics had lower disease activity markers than NHW based on CRP (OR: 0.5, P\u202f=\u202f.005), Hgb (OR: 0.4, P\u202f&amp;lt;\u202f.0001), albumin (OR: 0.7, P\u202f&amp;lt;\u202f.0001), and WBC (OR: 0.5, P\u202f&amp;lt;\u202f.0001). Geographic distribution of advanced IBD therapy showed clustered areas in southern and northern Florida.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data show an improved access to care pattern in Hispanic patients. However, disparities still exist, and this is evident in the healthcare utilization trends observed among non-Hispanic Black patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izae219","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T01:20:01Z","timestamp":1725585601000},"page":"344-350","source":"Crossref","is-referenced-by-count":4,"title":["Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-9394","authenticated-orcid":false,"given":"Fatima S","family":"Hussain","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Miami , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Potlach","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Chi","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Gurka","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Health Outcomes & Biomedical Informatics, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddh","family":"Setya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naueen A","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana M","family":"Damas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kerman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T","family":"Abreu","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Miami , Miami, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida , Gainesville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"issue":"6","key":"2025021012304968800_CIT0001","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology."},{"key":"2025021012304968800_CIT0002","volume-title":"US 2020 Census","author":"United States Census Bureau"},{"issue":"2","key":"2025021012304968800_CIT0003","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/ibd\/izac124","article-title":"The current state of care for Black and Hispanic inflammatory bowel disease patients","volume":"29","author":"Liu","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025021012304968800_CIT0004","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ibd.22986","article-title":"Systematic review: the role of race and socioeconomic factors on IBD healthcare delivery and effectiveness","volume":"19","author":"Sewell","year":"2013","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025021012304968800_CIT0005","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ajg.2012.393","article-title":"Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study","volume":"108","author":"Damas","year":"2013","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2025021012304968800_CIT0006","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.crohns.2013.09.001","article-title":"National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States","volume":"8","author":"Nguyen","year":"2014","journal-title":"J Crohns Colitis."},{"issue":"8","key":"2025021012304968800_CIT0007","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/ajg.2009.190","article-title":"Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review","volume":"104","author":"Hou","year":"2009","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"2025021012304968800_CIT0008","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1155\/2014\/941245","article-title":"Defining quality indicators for best-practice management of inflammatory bowel disease in Canada","volume":"28","author":"Nguyen","year":"2014","journal-title":"Can J Gastroenterol Hepatol."},{"issue":"2","key":"2025021012304968800_CIT0009","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.gastro.2013.10.027","article-title":"Increased effectiveness of early therapy with anti-tumor necrosis factor-alpha vs an immunomodulator in children with Crohn\u2019s disease","volume":"146","author":"Walters","year":"2014","journal-title":"Gastroenterology."},{"issue":"12","key":"2025021012304968800_CIT0010","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/ibd.22925","article-title":"Response to biologic therapy in Crohn\u2019s disease is improved with early treatment: an analysis of health claims data","volume":"18","author":"Rubin","year":"2012","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2025021012304968800_CIT0011","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.dld.2014.07.168","article-title":"Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: results from two referral centres","volume":"46","author":"Mandel","year":"2014","journal-title":"Dig Liver Dis."},{"issue":"4","key":"2025021012304968800_CIT0012","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/MIB.0000000000000679","article-title":"Anti-TNF therapy within 2 years of Crohn\u2019s disease diagnosis improves patient outcomes: a retrospective cohort study","volume":"22","author":"Ma","year":"2016","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2025021012304968800_CIT0013","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/ibd\/izz059","article-title":"The role of early biologic therapy in inflammatory bowel disease","volume":"25","author":"Berg","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2025021012304968800_CIT0014","author":"Data Summary of\u202fOneFlorida Clinical Research Consortium"},{"key":"2025021012304968800_CIT0015","doi-asserted-by":"publisher","first-page":"3467419","DOI":"10.1155\/2020\/3467419","article-title":"The relationship between C-reactive protein\/albumin ratio and disease activity in patients with inflammatory bowel disease","author":"Chen","year":"2020","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"2025021012304968800_CIT0016","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands","year":"2015","journal-title":"Gastroenterology."},{"issue":"2","key":"2025021012304968800_CIT0017","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/gutjnl-2016-312648","article-title":"Development of an index to define overall disease severity in IBD","volume":"67","author":"Siegel","year":"2018","journal-title":"Gut."},{"key":"2025021012304968800_CIT0018","volume-title":"Hispanic Americans\u2019 Experiences with Health Care","author":"Nadeem","year":"2022"},{"issue":"169","key":"2025021012304968800_CIT0019","first-page":"1","article-title":"Demographic variation in health insurance coverage: United States, 2020","author":"Cha","year":"2022","journal-title":"Natl Health Stat Report"},{"key":"2025021012304968800_CIT0020","author":"OneFlorida Clinical Research Consortium","year":".","journal-title":"General Insurance Data"},{"issue":"10","key":"2025021012304968800_CIT0021","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/ajg.2010.202","article-title":"Racial disparities in utilization of specialist care and medications in inflammatory bowel disease","volume":"105","author":"Nguyen","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"2025021012304968800_CIT0022","doi-asserted-by":"publisher","first-page":"17562848221079162","DOI":"10.1177\/17562848221079162","article-title":"Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD","volume":"15","author":"Damas","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"2025021012304968800_CIT0023","doi-asserted-by":"crossref","DOI":"10.32473\/ufjur.25.133020","volume-title":"Vulnerable Patients With Inflammatory Bowel Disease: Data From the OneFlorida Clinical Research Consortium","author":"Potlach","year":"."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae219\/59341301\/izae219.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/344\/59341301\/izae219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/344\/59341301\/izae219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T07:38:25Z","timestamp":1739173105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/2\/344\/7775394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,9,25]]},"published-print":{"date-parts":[[2025,2,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae219","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,9,25]]}}}